A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00357370. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Study of the Efficacy and Safety of BMS-512148 on Glycemic Control in Subjects With Type 2 Diabetes Treated Aggressively But Not Controlled on Combination Antihyperglycemic Therapy With Metformin and/or Thiazolidinedione (TZD) and Insulin.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to learn if BMS-512148, added to insulin and one or two anti-diabetes medications (metformin and/or pioglitazone or rosiglitazone), can help reduce the blood sugar levels compared to insulin and one or two anti-diabetes medications (metformin and/or pioglitazone or rosiglitazone) alone, in subjects with type 2 diabetes. The safety of this treatment will also be studied.
Study identification
- NCT ID
- NCT00357370
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2006 (Type not available)
- Primary completion
- Mar 2008 (Actual)
- Completion
- Mar 2008 (Actual)
- Last update posted
- May 11, 2017
2006 – 2008
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nea Clinic | Jonesboro | Arkansas | 72401 | — |
| Valley Research | Fresno | California | 93720 | — |
| Bernstein, Richard | Greenbrae | California | 94904 | — |
| Jacksonville Center For Clinical Research | Jacksonville | Florida | 32205 | — |
| Endocrine Research Solutions, Inc. | Roswell | Georgia | 30076 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Model Clinical Research Llc | Baltimore | Maryland | 21204 | — |
| University Of Michigan | Ann Arbor | Michigan | 48109 | — |
| St. Louis Center For Clinical Research | St Louis | Missouri | 63128 | — |
| Suny Upstate Medical University | Syracuse | New York | 13210 | — |
| Mountain Diabetes And Endocrine Center | Asheville | North Carolina | 28801 | — |
| Your Diabetes Endocrine Nutrition Group | Mentor | Ohio | 44060 | — |
| Research Institute Of Dallas, P.A. | Dallas | Texas | 75231 | — |
| Diabetes And Glandular Disease Research Associates, P.A. | San Antonio | Texas | 78229 | — |
| Rainier Clinical Research Center | Renton | Washington | 98055 | — |
| Advanced Healthcare S.C. | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00357370, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2017 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.